在 COVID 大流行期间,糖尿病患者与 COVID 无关的死亡人数增加

Iskandar Idris DM
{"title":"在 COVID 大流行期间,糖尿病患者与 COVID 无关的死亡人数增加","authors":"Iskandar Idris DM","doi":"10.1002/doi2.87","DOIUrl":null,"url":null,"abstract":"<p>Recurrent lockdowns and public health measures throughout the COVID-19 pandemic have restricted access to routine diabetes care, routine follow-ups and access to medications. These disruptions have resulted in adverse diabetes outcomes, but the true effects of the COVID-19 pandemic on long-term outcomes and mortality in people with diabetes are still unclear. A recent international study<span><sup>1</sup></span> commissioned by the World Health organization aimed to identify the impact of disruptions caused by COVID-19 on clinical outcomes in people with diabetes. This was a systematic review of the available literature and included 138 studies (<i>n</i> &gt; 1 000 000 people). All studies compared pre-pandemic with pandemic periods. All-cause mortality (six studies) and diabetes-related mortality (13 studies) showed consistent increases, and most studies indicated increases in sight loss (six studies). One study found that, in 2021, there was an 11% rise in non-COVID-related deaths among people with diabetes compared with 2019.</p><p>In children and adolescents, most studies showed increases in diabetic ketoacidosis frequency or severity, some due to new-onset diabetes (69 studies). While there was a decrease in hospital admissions in adults, increases in diabetes-related admissions to paediatric intensive care units were reported (35 studies). The latter seemed to be very consistent across countries. No significant impact was noted for diabetic foot ulcer presentations (nine studies), emergency department admissions (nine studies) and overall amputation rates (20 studies). No studies investigated renal failure. The adverse impact appeared to be most pronounced for females, younger people and racial and ethnic minority groups. Findings from this study highlight the need to have a flexible and adaptable health care system to ensure maintenance of good clinical outcomes from people living with chronic disease like diabetes in the face of future epidemics. Recognizing and addressing disparities and inequalities in healthcare are crucial.</p>","PeriodicalId":100370,"journal":{"name":"Diabetes, Obesity and Metabolism Now","volume":"2 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/doi2.87","citationCount":"0","resultStr":"{\"title\":\"Increased non-COVID-related death among people with diabetes during the COVID pandemic\",\"authors\":\"Iskandar Idris DM\",\"doi\":\"10.1002/doi2.87\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Recurrent lockdowns and public health measures throughout the COVID-19 pandemic have restricted access to routine diabetes care, routine follow-ups and access to medications. These disruptions have resulted in adverse diabetes outcomes, but the true effects of the COVID-19 pandemic on long-term outcomes and mortality in people with diabetes are still unclear. A recent international study<span><sup>1</sup></span> commissioned by the World Health organization aimed to identify the impact of disruptions caused by COVID-19 on clinical outcomes in people with diabetes. This was a systematic review of the available literature and included 138 studies (<i>n</i> &gt; 1 000 000 people). All studies compared pre-pandemic with pandemic periods. All-cause mortality (six studies) and diabetes-related mortality (13 studies) showed consistent increases, and most studies indicated increases in sight loss (six studies). One study found that, in 2021, there was an 11% rise in non-COVID-related deaths among people with diabetes compared with 2019.</p><p>In children and adolescents, most studies showed increases in diabetic ketoacidosis frequency or severity, some due to new-onset diabetes (69 studies). While there was a decrease in hospital admissions in adults, increases in diabetes-related admissions to paediatric intensive care units were reported (35 studies). The latter seemed to be very consistent across countries. No significant impact was noted for diabetic foot ulcer presentations (nine studies), emergency department admissions (nine studies) and overall amputation rates (20 studies). No studies investigated renal failure. The adverse impact appeared to be most pronounced for females, younger people and racial and ethnic minority groups. Findings from this study highlight the need to have a flexible and adaptable health care system to ensure maintenance of good clinical outcomes from people living with chronic disease like diabetes in the face of future epidemics. Recognizing and addressing disparities and inequalities in healthcare are crucial.</p>\",\"PeriodicalId\":100370,\"journal\":{\"name\":\"Diabetes, Obesity and Metabolism Now\",\"volume\":\"2 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/doi2.87\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity and Metabolism Now\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/doi2.87\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity and Metabolism Now","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/doi2.87","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在整个 COVID-19 大流行期间,反复出现的封锁和公共卫生措施限制了糖尿病患者获得常规护理、常规随访和药物治疗的机会。这些干扰导致了不良的糖尿病结果,但 COVID-19 大流行对糖尿病患者长期结果和死亡率的真正影响仍不清楚。世界卫生组织最近委托开展了一项国际研究1 ,旨在确定 COVID-19 造成的混乱对糖尿病患者临床治疗效果的影响。该研究对现有文献进行了系统回顾,共纳入 138 项研究(n > 1 000 000 人)。所有研究都对大流行前和大流行期间进行了比较。全因死亡率(6 项研究)和糖尿病相关死亡率(13 项研究)持续上升,大多数研究表明失明率上升(6 项研究)。一项研究发现,与 2019 年相比,2021 年糖尿病患者中与 COVID 无关的死亡人数增加了 11%。在儿童和青少年中,大多数研究显示糖尿病酮症酸中毒的频率或严重程度增加,其中一些是由于新发糖尿病引起的(69 项研究)。虽然成人的入院率有所下降,但儿科重症监护室与糖尿病相关的入院率却有所上升(35 项研究)。各国的情况似乎非常一致。糖尿病足溃疡的发病率(9 项研究)、急诊室入院率(9 项研究)和总体截肢率(20 项研究)均未见明显影响。没有研究对肾衰竭进行调查。对女性、年轻人以及少数民族群体的不利影响似乎最为明显。这项研究的结果突出表明,面对未来的流行病,有必要建立一个灵活、适应性强的医疗保健系统,以确保糖尿病等慢性病患者保持良好的临床治疗效果。认识并解决医疗保健中的差距和不平等问题至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Increased non-COVID-related death among people with diabetes during the COVID pandemic

Recurrent lockdowns and public health measures throughout the COVID-19 pandemic have restricted access to routine diabetes care, routine follow-ups and access to medications. These disruptions have resulted in adverse diabetes outcomes, but the true effects of the COVID-19 pandemic on long-term outcomes and mortality in people with diabetes are still unclear. A recent international study1 commissioned by the World Health organization aimed to identify the impact of disruptions caused by COVID-19 on clinical outcomes in people with diabetes. This was a systematic review of the available literature and included 138 studies (n > 1 000 000 people). All studies compared pre-pandemic with pandemic periods. All-cause mortality (six studies) and diabetes-related mortality (13 studies) showed consistent increases, and most studies indicated increases in sight loss (six studies). One study found that, in 2021, there was an 11% rise in non-COVID-related deaths among people with diabetes compared with 2019.

In children and adolescents, most studies showed increases in diabetic ketoacidosis frequency or severity, some due to new-onset diabetes (69 studies). While there was a decrease in hospital admissions in adults, increases in diabetes-related admissions to paediatric intensive care units were reported (35 studies). The latter seemed to be very consistent across countries. No significant impact was noted for diabetic foot ulcer presentations (nine studies), emergency department admissions (nine studies) and overall amputation rates (20 studies). No studies investigated renal failure. The adverse impact appeared to be most pronounced for females, younger people and racial and ethnic minority groups. Findings from this study highlight the need to have a flexible and adaptable health care system to ensure maintenance of good clinical outcomes from people living with chronic disease like diabetes in the face of future epidemics. Recognizing and addressing disparities and inequalities in healthcare are crucial.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity Multi-society consensus guidance on handling of GLP-1 therapy prior to general anaesthesia Issue Information Issue Information Precision medicine approach to detect obese people who are at high risk of developing diabetes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1